When autophagy is inhibited by 3-Methyladenine (3-MA) or ATG5 silencing in AML-MSCs, their cell cycle is arrested in G1, and the expression of CXCL12, which is responsible for the interaction of leukemic and stromal cells in the BM, is significantly reduced. The gene discussed is ATG5; the disease is acute myeloid leukemia.